Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Quarterly results
Appointed director
ESPEY MFG & ELECTRONICS CORP (ESP)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
03/09/2021
GN
Espey Suspends Dividend
02/16/2021
GN
Espey Mfg. & Electronics Corp. reports second quarter results
12/07/2020
GN
Espey Declares Regular Quarterly Dividend of $0.25 Per Share
09/21/2020
GN
Espey Mfg. & Electronics Corp. reports Fourth Quarter and Year-end results as well as Announces Regular Quarterly Dividend of $0.25 Per Share
06/08/2020
GN
Espey Declares Regular Quarterly Dividend of $0.25 Per Share
03/09/2020
GN
Espey Declares Regular Quarterly Dividend of $0.25 Per Share
02/13/2020
GN
Espey Mfg. & Electronics Corp. reports record backlog and second quarter results
10/30/2019
GN
ESPERITE (ESP) is not bankrupt
10/01/2019
GN
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
09/19/2019
GN
CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
09/16/2019
GN
Espey Mfg. & Electronics Corp. reports fourth quarter and year-end results
09/09/2019
GN
Espey Declares Regular Quarterly Dividend of $0.25 Per Share
08/27/2019
GN
ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE'S FAMILY STEM CELL BANKING BUSINESS
07/04/2019
GN
Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
07/02/2019
GN
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
07/01/2019
GN
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260'000 FAMILIES FOR THEIR TRUST AND CONFIDENCE.
07/01/2019
GN
ESPERITE NV (ESP) MIT CRYOSAVE BESTÄTIGT DIE SICHERHEIT ALLER GELAGERTEN PROBEN UND DANKT DEN 260'000 FAMILIEN FÜR IHR VERTRAUEN.
07/01/2019
GN
ESPERITE NV (ESP) CON CRYOSAVE CONFIRMA LA SEGURIDAD DE TODAS LAS MUESTRAS ALMACENADAS Y AGRADECE A LAS 260.000 FAMILIAS SU CONFIANZA.
07/01/2019
GN
ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
07/01/2019
GN
ESPERITE NV (ESP) CON CRYOSAVE CONFERMA LA SICUREZZA DI TUTTI I CAMPIONI CONSERVATI E RINGRAZIA LE 260'000 FAMIGLIE PER LA LORO FIDUCIA.
07/01/2019
GN
ESPERITE NV (ESP) MET CRYOSAVE BEVESTIGT DE VEILIGHEID VAN ALLE OPGESLAGEN STALEN EN DANKT DE 260.000 FAMILIES VOOR HUN VERTROUWEN.
07/01/2019
GN
ESPERITE NV (ESP) Z KRIOZAWA POTWIERDZA BEZPIECZENSTWO WSZYSTKICH PRZECHOWYWANYCH PRÓBEK I DZIEKUJE 260'000 RODZINOM ZA ICH ZAUFANIE I PEWNOSC SIEBIE.
07/01/2019
GN
ESPERITE NV (ESP) COM CRYOSAVE CONFIRMA A SEGURANÇA DE TODAS AS AMOSTRAS ARMAZENADAS E AGRADECE ÀS 260.000 FAMÍLIAS PELA SUA CONFIANÇA.
07/01/2019
GN
ESPERITE NV (?????????) ? CRYOSAVE ???????????? ???????????? ???? ?????????? ???????? ? ??????????? 260'000 ????? ?? ??????? ? ???????????.
07/01/2019
GN
Az ESPERITE NV (ESP) CRYOSAVE-RÓL MEGBÍZHATÓ A MINDEN MINTABAN LÉTETT MINDEN BIZTONSÁGÁNAK ÉS K??SZÜLÉSE A HÍVÁSRA ÉS A MEGBÍZHATÓSÁGRA.
06/30/2019
GN
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
06/28/2019
GN
Esperite N.V.: Update to the market on the publication of the Annual Report 2018
06/14/2019
GN
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
06/13/2019
GN
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
06/10/2019
GN
Espey Declares Regular Quarterly Dividend of $0.25 Per Share
06/04/2019
GN
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
06/04/2019
GN
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
05/29/2019
GN
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
05/19/2019
GN
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy